Jonathan Goodman, MPhil

Researchers sought to determine whether axi-cel would improve overall survival rates in patients with LBCL.

Researchers sought to determine if a chemotherapy-free regimen including inotuzumab ozogamicin and blinatumomab would be effective in elderly patients with B-cell ALL.

Researchers sought to determine whether belamaf would improve PFS rates compared with Pd among patients with relapsed/refractory multiple myeloma.

Researchers sought to determine whether ruxolitinib would improve clinical outcomes in patients with treatment-resistant PV.

Researchers sought to determine whether lenalidomide maintenance would improve outcomes in patients with high-risk non-Hodgkin lymphoma who receive HDT/ASCT .

Researchers sought to determine whether genetic markers may indicate a high likelihood of benefitting from lenalidomide maintenance in patents with multiple myeloma who undergo ASCT.

Researchers sought to determine which genetic variants could be linked with the predisposition for developing Hodgkin lymphoma.

Researchers sought to determine whether treatment with hydroxyurea for patients with MPNs would lead to a higher risk of secondary malignancies.

Researchers sought to determine whether conversion of MRD status during maintenance would affect risk of disease progression in patients with MM.

Researchers sought to determine whether rituximab maintenance therapy would have a clinical benefit in elderly patients with mantle cell lymphoma.